Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction.
Ontology highlight
ABSTRACT: Duchenne Muscular Dystrophy (DMD) is a fatal muscle wasting disease manifested in young boys, for which there is no current cure. We have shown that the amino acid taurine is safe and effective at preventing dystropathology in the mdx mouse model for DMD. This study aimed to establish if treating growing mdx mice with a higher dose of taurine was more effective at improving strength and reducing inflammation and oxidative stress. Mice were treated with a dose of taurine estimated to be 16 g/kg/day, in drinking water from 1-6 weeks of age, after which in vivo and ex vivo muscle strength was assessed, as were measures of inflammation, oxidative stress and taurine metabolism. While the dose did decrease inflammation and protein oxidation in dystrophic muscles, there was no improvement in musc
SUBMITTER: Terrill JR
PROVIDER: S-EPMC5667875 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
ACCESS DATA